FDA Drug recall D-082-2014
Double Therapy Inj
- FDA Drug
- Class II
- terminated
- Published 2013-12-11
On 2013-12-11 the FDA classified a Class II recall of Double Therapy Inj by Main Street Family Pharmacy, citing the firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-082-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-05-28 |
| Published | 2013-12-11 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Main Street Family Pharmacy |
| Distribution | US |
Product
Double Therapy Inj. SS ML, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200
Reason
The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
Identifiers
| code_info | all codes distributed prior to and including 05/23/2013 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-082-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.